Floatz logo

PROPARACAINE

Dry Eye

Tufts Medical CenterSmall moleculeDormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
89/ 100

Competitive context

6 Active assets in the Dry Eye cohort.

Asset / SponsorPhaseRating
CYCLOSPORIN A
Barbara Burgos Blasco
Phase 4BBB
Humulin R
Barbara Burgos Blasco
Phase 4BB
Insulin Human
Khyber Teaching Hospital
Phase 4BB
Azithromycin
University of California, San Francisco
Phase 4BB
Diluent
Instituto de Oftalmología Fundación Conde de Valenciana
Phase 3B
Acthar Gel
Toyos Clinic
Phase 4B
Acthar
Toyos Clinic
Phase 4CCC
Sodium Hyaluronate
Peking University Third Hospital
N/AD

Same molecule, other indications

PROPARACAINE is also rated in:

Neuropathic PainDormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →